Industry Education Series: Hemgenix - Gene Therapy Treatment for Hemophilia B

CSL Behring is having a free presentation and dinner for all families in NV with Hemophilia B. This will be a branded presentation about their new Gene Therapy product Hemgenix, a treatment for males over 18 years old with Hemophilia B. There will be opportunities to have questions answered by a professional with experience administering the treatment.
This event is for individuals with Hemophilia B and/or family & caregivers of an individual with Hemophilia B.